Global Eye Melanoma Market, By Site (Uvea, Sclera and Retina), By Diagnosis (Imaging, Biopsy and Eye exam), By Treatment (Surgery, Radiation therapy and Laser treatment), By End-User (Hospital & Clinics and Academic Institutes) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Name: Global Eye Melanoma Market, By Site (Uvea, Sclera and Retina), By Diagnosis (Imaging, Biopsy and Eye exam), By Treatment (Surgery, Radiation therapy and Laser treatment), By End-User (Hospital & Clinics and Academic Institutes) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030
Brand: Prophecy Market Insights
SKU: Pharmaceutical
Price: 3450 USD
Availability: InStock
Rating: 3.53 (46 reviews)

Report Code: PMI471921 | Publish Date: August 2023 | No. of Pages: 192

Global Eye Melanoma Market Overview

Melanoma is a malignancy that affects cells that produce melanin. Eye melanoma, also known as ocular melanoma, is a cancer that develops in the center of the eye's three layers, namely the sclera, retina, and uvea. Early symptoms of eye melanoma include a sensation of flashes or specks of dust in vision (floaters), a growing dark spot on the iris, a change in the shape of the pupil in the center of the eye, poor or blurry vision in one eye, and loss of peripheral vision, but later symptoms include a sensation of flashes or specks of dust in vision (floaters), a growing dark spot on the iris, a change in the shape of the Trans pupillary thermotherapy, surgical resection procedures, and laser techniques are also used in the treatment.

Impact of Covid-19 pandemic on market

The global eye melanoma market experienced a significant financial damage as a result of its exposure to the massive impact of the new Coronavirus, which has wreaked havoc on all other markets. Eye melanoma is treated with advanced methods such as transpupillary thermotherapy, laser procedures, and surgical resection. As a result of the increase in connected instances, authorities have been compelled to speed up additional research and development operations while also spending more money on the process, allowing the market to grow stronger and more stable even in the midst of a fatal virus pandemic—COVID 19.

Global Eye Melanoma Market Dynamics

Growth in business operations by emerging and small sized players

The rising prevalence of eye cancer, the ageing population, the rise in healthcare spending, and government support for research and development for new and better treatments have all contributed to the market's expansion. The market is being driven by two major factors: rising cancer incidence and an ageing population. The key companies in the market are increasing their research and development investments in the field of ocular cancer, which is also fueling the industry's growth.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Eye Melanoma Market Segmentation

The Global Eye Melanoma market is segmented based on site, diagnosis, treatment, end-user, and region.

On the basis of Site, the global Eye Melanoma market is segmented into Uvea, Sclera and Retina. Based on Diagnosis, the target market is segmented into Imaging, Biopsy and Eye exam. On the basis of Treatment, the target market is segmented into Surgery, Radiation therapy and Laser treatment. On the basis of End-User, the target market is segmented into Hospitals & Clinics and Academic Institutes.

Regional Insights:

On region the global Eye Melanoma market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Americas dominate the global eye melanoma market due to increased disease prevalence and high healthcare spending. Furthermore, the rise of the American market has been fueled by an increase in the number of patients and a shift in lifestyle. Due to increased research and development, a big patient population, and well-developed healthcare, Europe is the second largest market for eye melanoma. Asia Pacific is the fastest expanding region for eye melanoma because to its enormous patient population, quickly growing economies, and rising healthcare expenses.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2030
Market representation	Revenue in USD Million & CAGR from 2020 – 2030
Market Segmentation	By Site- Uvea, Sclera and Retina By Diagnosis– Imaging, Biopsy and Eye exam By Treatment– Surgery, Radiation therapy and Laser treatment By End-User – Hospitals & Clinics and Academic Institute
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global Eye Melanoma market report based on site, diagnosis, treatment, end-user, application, and region.

Global Eye Melanoma Market, By Region:

- - North America
    - - U.S.
      - Canada
  - Europe
    - - Germany
      - UK
      - France
      - Russia
      - Italy
      - Rest of Europe
  - Asia Pacific
    - - China
      - India
      - Japan
      - South Korea
      - Rest of Asia Pacific
  - Latin America
    - - Brazil
      - Mexico
      - Rest of Latin America
  - Middle East & Africa
    - - GCC
      - Israel
      - South Africa
      - Rest of Middle East & Africa

Global Eye Melanoma Market Key Players

Global Eye Melanoma Market

The key players operating in the global Eye Melanoma market includes Merck & Co., Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, AbbVie Inc., Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, Bayer AG, Johnson & Johnson Services, Inc., , Carl Zeiss AG, Optovue, Incorporated, Siemens, Koninklijke Philips N.V, Castle Biosciences, Inc., Spectrum Pharmaceuticals, Inc., Gilead Sciences, Inc. and others. The global eye melanoma market is extremely fragmented, and prominent competitors have employed a variety of strategies to expand their footprints in this market, including new product releases, expansions, agreements, joint ventures, partnerships, acquisitions, and others.

Global Eye Melanoma Market Company Profile

Merck & Co, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies

F. Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Sanofi
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
AbbVie Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Amgen Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
AstraZeneca
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Bristol-Myers Squibb Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Bayer AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Johnson & Johnson Services, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Carl Zeiss AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Optovue
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Siemens
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Koninklijke Philips N.V
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Castle Biosciences, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Spectrum Pharmaceuticals, Inc.,
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Gilead Sciences, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies

Global Eye Melanoma Market Table of Contents

Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
Research Methodology
- Research data
- Primary Data
  - Primary Interviews
  - Primary Breakdown
  - Key data from Primary Sources
  - Key Thickness Insights
- Secondary Data
  - Major Secondary Sources
  - Secondary Sources
- Market Estimation
- Top-Down Approach
  - Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
  - Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
Market Purview
- Executive Summary
- Key Findings—Global Outlook for Eye Melanoma Strategies
  - Key Questions this Study will Answer
  - Market Snippet, By Site
  - Market Snippet, By Diagnosis
  - Market Snippet, By Treatment
  - Market Snippet, By End-User
  - Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
  - Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
Global Eye Melanoma Market, By Site, 2020 – 2030, (US$ Mn)
- Overview
  - Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
  - Y-o-Y Growth Analysis (%), 2020 – 2030
  - Segment Trends
- Uvea
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Sclera
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Retina
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

Global Eye Melanoma Market, By Diagnosis, 2020 – 2030, (US$ Mn)
- Overview
  - Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
  - Y-o-Y Growth Analysis (%), 2020 – 2030
  - Segment Trends
- Imaging
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Biopsy
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Eye exam
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
Global Eye Melanoma Market, By Treatment, 2020 – 2030, (US$ Mn)
- Overview
  - Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
  - Y-o-Y Growth Analysis (%), 2020 – 2030
  - Segment Trends
- Surgery
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Radiation therapy
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Laser treatment
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
Global Eye Melanoma Market, By End-User, 2020 – 2030, (US$ Mn)
- Overview
  - Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
  - Y-o-Y Growth Analysis (%), 2020 – 2030
  - Segment Trends
- Hospitals & Clinics
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Academic Institutes
  - Overview
  - Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

Global Eye Melanoma Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
  - Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
  - Y-o-Y Growth Analysis (%), 2020 – 2030
  - Regional Trends
- North America
  - Market Size and Forecast (US$ Mn), By Site, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Diagnosis, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
    - U.S.
    - Canada
- Europe
  - Market Size and Forecast (US$ Mn), By Site, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Diagnosis, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
    - UK
    - France
    - Germany
    - Russia
    - Italy
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast (US$ Mn), By Site, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Diagnosis, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
    - India
    - Japan
    - South Korea
    - China
    - Rest of Asia Pacific
- Latin America
  - Market Size and Forecast (US$ Mn), By Site, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Diagnosis, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
    - Brazil
    - Mexico
    - Rest of Latin America
- Middle East & Africa
  - Market Size and Forecast (US$ Mn), By Site, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Diagnosis, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
  - Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
    - GCC
    - Israel
    - South Africa
    - Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
Company Profiles

Merck & Co. Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Novartis AG
Pfizer Inc.
Sanofi
AbbVie Inc.
Amgen Inc.
AstraZeneca
Bristol-Myers Squibb Company
Bayer AG
Johnson & Johnson Services, Inc.
Carl Zeiss AG
Optovue
Incorporated
Siemens
Koninklijke Philips N.V
Castle Biosciences, Inc.
Spectrum Pharmaceuticals, Inc.,
Gilead Sciences, Inc.
Others

The Last Word

- Future Impact
- About Us
- Contact

FAQs

What is the scope of the market research report?

The global eye melanoma market is segmented based on site, diagnosis, treatment, end-user, and region.

What are the growing factors related with the market global eye melanoma growth?

What are the regions considered in the report & which region will dominate the market?

The Americas dominate the global eye melanoma market due to increased disease prevalence and high healthcare spending.

What are the key strategies adopted by the leading players in the global eye melanoma market?

The global eye melanoma market is extremely fragmented, and prominent competitors have employed a variety of strategies to expand their footprints in this market, including new product releases, expansions, agreements, joint ventures, partnerships, acquisitions, and others.

Healthcare

Information and Technology

Electronics

Chemicals and materials

Others